1. Amin M, Hersh CM. Updates and advances in multiple sclerosis neurotherapeutics. Neurodegenerative disease management. 2023; 13(1): 47-70. [
DOI:10.2217/nmt-2021-0058]
2. Emilio Portaccioa E, et al. Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. The Lancet Regional Health - Europe, 2024; 44: 100977 2023. [
DOI:10.1016/j.lanepe.2024.100977]
3. World Health Organization. Multiple Sclerosis Fact Sheet. 2023.
4. Amini P, et al. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series. BMC Neurol, 2021; 21: 235. [
DOI:10.1186/s12883-021-02281-x]
5. Mohr DC, Pelletier D. A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain, behavior, and immunity. 2006;20(1):27-36. [
DOI:10.1016/j.bbi.2005.03.011]
6. Lerdal A, Gulowsen Celius E, Krupp L, Dahl AA. A prospective study of patterns of fatigue in multiple sclerosis. European journal of neurology. 2007;14(12):1338-43. [
DOI:10.1111/j.1468-1331.2007.01974.x]
7. Grossman, P., Kollhorst, B., Fliege, H., Kullowatz, A., & Krohn-Grimberghe, B. (2023). Neuropsychiatric implications of fatigue in multiple sclerosis. Journal of Neurology, 270(5), 1321-1332.
8. Yang T-t, Wang L, Deng X-y, Yu G. Pharmacological treatments for fatigue in patients with multiple sclerosis: a systematic review and meta-analysis. Journal of the neurological sciences. 2017;380:25661. [
DOI:10.1016/j.jns.2017.07.042]
9. MS Foundation. Coping with anxiety in multiple sclerosis, 2023. Available at: https://msfocus.org
10. Altıntaş M, Korkut S. Investigation of coronavirus anxiety, health anxiety, and anxiety symptom levels in vertigo patients during COVID-19 pandemic. Brazilian Journal of Otorhinolaryngology. 2023;89(2):313-20. [
DOI:10.1016/j.bjorl.2022.11.003]
11. Diamond PR, Dysch L, Daniels J. Health anxiety in stroke survivors: a cross-sectional study on the prevalence of health anxiety in stroke survivors and its impact on quality of life. Disability and Rehabilitation. 2023;45(1):27-33. [
DOI:10.1080/09638288.2021.2022778]
12. Mansouri Koryani R, Bassak Nejad S, Mehrabizadeh Honarmand M, Majdinasab N. Effectiveness of Compassion Focused Acceptance and Commitment Therapy on Psychological Flexibility and Psychological Distress in Patients With Multiple Sclerosis. Iranian Journal of Psychiatry and Clinical Psychology. 2022;28(2):222-35. [
DOI:10.32598/ijpcp.28.2.3747.1]
13. Aboutalebi H, Yazdchi N, Smkhani Akbarinejhad H. Effectiveness of compassion-focused therapy on death anxiety and quality of life among women with multiple sclerosis. Medical Science Journal of Islamic Azad Univesity-Tehran Medical Branch. 2022; 32 (1): 101-92. [
DOI:10.52547/iau.32.1.92]
14. Khanali Lou R, Lotfi Kashani F. The effectiveness of cognitive-behavioral therapy on depression and its resulting dysfunctional concerns in multiple sclerosis. Islamic Life Journal. 2020;3:163-72.
15. Shareh H, Robati Z. Effect of Cognitive-Behavioral Group Therapy on Pain Self-efficacy, Fatigue, Life Expectancy and Depression in Patients With Multiple Sclerosis: A Randomized Controlled Clinical Trial. IJPCP 2021; 26 (4) :418-431. [
DOI:10.32598/ijpcp.26.3.225.11]
16. Maghsoudloo F, Sanagouye Moharer G, Shirazi M. Effectiveness of Cognitive Behavioral Therapy in Reducing Anxiety Thoughts and Life Expectancy in Women with MS. RJMS 2023; 30 (1) :206-221
17. Gay MC, Cassedanne F, Barbot F, Vaugier I, Thomas S, Manchon E, et al. Long-term effectiveness of a cognitive behavioural therapy (CBT) in the management of fatigue in patients with relapsing remitting multiple sclerosis (RRMS): a multicentre, randomised, open-label, controlled trial versus standard care. Journal of Neurology, Neurosurgery & Psychiatry. 2024;95(2):158-66. [
DOI:10.1136/jnnp-2023-331537]
18. Zarotti N, Eccles F, Broyd A, Longinotti C, Mobley A, Simpson J. Third wave cognitive behavioural therapies for people with multiple sclerosis: a scoping review. Disability and Rehabilitation. 2023; 45(10): 1720-35. [
DOI:10.1080/09638288.2022.2069292]
19. Ehde DM, Alschuler KN, Day MA, Ciol MA, Kaylor ML, Altman JK, et al. Mindfulness-based cognitive therapy and cognitive behavioral therapy for chronic pain in multiple sclerosis: a randomized controlled trial protocol. Trials. 2019;20: 1-12. [
DOI:10.1186/s13063-019-3761-1]
20. Wever C. Beyond psychological truth deconstructing western deficit-oriented psychology and the co-construction of alternative psychologies in narrative practice. International Journal of Narrative Therapy & Community Work. 2015(1):11-25.
21. Soghari Karbalai Herfteh FaNF, Abbas and Deljooi Sarkesh, Zahra. Comparison of the effect of narrative therapy and commitment and acceptance based therapy (ACT) on body image concerns in multiple sclerosis (MS). First National Conference on Futurology Educational Sciences and Psychology, Shiraz. 2023.
22. Banisafar A, Ahi Q, Mansouri A, Bahreynian A. Investigating the effectiveness of narrative therapy on resilience and emotional regulation of cancer patients with low psychological toughness. Journal of Psychological Science. 2024;23(133):183-95.
23. Zolfalipormaleki S, Gamari Kivi H, Rezai Sharif A. Effectiveness of Narrative Therapy on Social Physique Anxiety in Obese and Overweight Women. Journal of Ardabil University of Medical Sciences. 2023;23(3): 91-278. [
DOI:10.61186/jarums.23.3.278]
24. Fazeli N, Soleimani Farsani S, Vakili Y, Ilanloo H. The Effectiveness of Narrative Therapy on Psychological Capital and a Sense of Coherence among Spouses of Individuals Undergoing Withdrawal. Scientific Quarterly Research on Addiction. 2022; 16(64): 218-197. [
DOI:10.52547/etiadpajohi.16.64.197]
25. Geng C, Zhang M, Zhang L, Yin H, Wang S. Effects of Narrative Exposure Therapy for Treating Depressive and Anxious Disorders: A Systematic Review and Meta-Analysis. Psychiatry Investigation. 2024;21(4):329. [
DOI:10.30773/pi.2023.0281]
26. Ya-Yi Z, Xiao-Juan L, Ming-Yu L, Xue-Ping G, Ling-Zhi H. Intervention effect of narrative therapy on non-suicidal self-injury in adolescents with depressive disorder: a prospective randomized controlled study. Chinese Journal of Contemporary Pediatrics. 2024;26(2).
27. Delavar A. educational and psychologycal Research, 4th edition, Virayesh publication institute.2023.
28. SHAHVARUGHI FA, Azimian M, Fallahpour M, Karimlou M. Evaluation of reliability and validity of the Persian version of Fatigue Severity Scale (FSS) among persons with multiple sclerosis. 2013.
29. Nargesi F, Izadi F, Kariminejad K, Rezaii Sharif A. The investigation of the reliability and validity of Persian version of Health anxiety questionnaire in students of Lorestan University of Medical Sciences. Quarterly of Educational Measurement. 2017;7(27):147-60.
30. Röttgering JG, Douw L, de Witt Hamer PC, Kouwenhoven MC, Würdinger T, van de Ven PM, et al. Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy. Trials. 2022;23(1):568. [
DOI:10.1186/s13063-022-06485-5]
31. Chen T, Wang R, Zhan Y, Ma X, Sun C, Li L. Effect of Narrative Therapy on the Psychological Status and Life Quality of Family Caregivers of Adolescents with First-episode Depression. Medicinal Plant. 2022;13(6):72-84.